AAAAAA
Results:
1-16
|
Results: 16
Authors:
Nord, E
Citation: E. Nord, The desirability of a condition versus the well being and worth of a person, HEALTH ECON, 10(7), 2001, pp. 579-581
Authors:
Gulbrandsen, N
Wisloff, F
Nord, E
Lenhoff, S
Hjorth, M
Westin, J
Citation: N. Gulbrandsen et al., Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma, EUR J HAEMA, 66(5), 2001, pp. 328-336
Authors:
Nord, E
Citation: E. Nord, Health state values from multiattribute utility instruments need correction, ANN MED, 33(5), 2001, pp. 371-374
Authors:
Arnesen, T
Nord, E
Citation: T. Arnesen et E. Nord, The value of DALY life: problems with ethics and validity of disability adjusted life years, LEPROSY REV, 71(2), 2000, pp. 123-127
Authors:
Stigum, H
Magnus, P
Samdal, HH
Nord, E
Citation: H. Stigum et al., Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model, INT J EPID, 29(6), 2000, pp. 1076-1084
Authors:
Eriksen, BO
Forde, OH
Kristiansen, IS
Nord, E
Pape, JF
Almdahl, SM
Hensrud, A
Jaeger, S
Murer, FA
Citation: Bo. Eriksen et al., Cost savings and health losses from reducing inappropriate admissions to adepartment of internal medicine, INT J TE A, 16(4), 2000, pp. 1147-1157
Authors:
Novak, EJ
Ortqvist, E
Nord, E
Edwall, L
Hampe, CS
Bekris, L
Persson, BE
Lernmark, A
Citation: Ej. Novak et al., Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function, DIABET CARE, 23(7), 2000, pp. 1019-1021
Authors:
Ubel, PA
Nord, E
Gold, M
Menzel, P
Prades, JLP
Richardson, J
Citation: Pa. Ubel et al., Improving value measurement in cost-effectiveness analysis, MED CARE, 38(9), 2000, pp. 892-901
Authors:
Wisloff, F
Gulbrandsen, N
Nord, E
Citation: F. Wisloff et al., Therapeutic options in the treatment of multiple myeloma - Pharmacoeconomic and quality-of-life considerations, PHARMACOECO, 16(4), 1999, pp. 329-341
Authors:
Nord, E
Citation: E. Nord, Towards cost-value analysis in health care?, HEAL CARE A, 7(2), 1999, pp. 167-175
Authors:
Nord, E
Pinto, JL
Richardson, J
Menzel, P
Ubel, P
Citation: E. Nord et al., Incorporating societal concerns for fairness in numerical valuations of health programmes, HEALTH ECON, 8(1), 1999, pp. 25-39
Authors:
Arnesen, T
Nord, E
Citation: T. Arnesen et E. Nord, The value of DALY life: problems with ethics and validity of disability adjusted life years, BR MED J, 319(7222), 1999, pp. 1423-1425
Authors:
Eriksen, BO
Kristiansen, IS
Nord, E
Pape, JF
Almdahl, SM
Hensrud, A
Jaeger, S
Citation: Bo. Eriksen et al., The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine, J INTERN M, 246(4), 1999, pp. 379-387
Authors:
Menzel, P
Gold, MR
Nord, E
Pinto-Prades, JL
Richardson, J
Ubel, P
Citation: P. Menzel et al., Toward a broader view of values in cost-effectiveness analysis of health, HAST CENT R, 29(3), 1999, pp. 7-15
Authors:
Persson, B
Westgren, M
Celsi, G
Nord, E
Ortqvist, E
Citation: B. Persson et al., Leptin concentrations in cord blood in normal newborn infants and offspring of diabetic mothers, HORMONE MET, 31(8), 1999, pp. 467-471
Authors:
Kristiansen, IS
Kvien, TK
Nord, E
Citation: Is. Kristiansen et al., Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis, ARTH RHEUM, 42(11), 1999, pp. 2293-2302
Risultati:
1-16
|